This company listing is no longer active
RDSM.Y Stock Overview
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for RDSM.Y from our risk checks.
DSM-Firmenich AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €33.85 |
| 52 Week High | €56.92 |
| 52 Week Low | €26.59 |
| Beta | 0.79 |
| 1 Month Change | 19.70% |
| 3 Month Change | -8.69% |
| 1 Year Change | -38.89% |
| 3 Year Change | 4.60% |
| 5 Year Change | 47.17% |
| Change since IPO | 941.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| RDSM.Y | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 15.8% | -2.9% | -3.7% |
| 1Y | -38.9% | 5.6% | 20.2% |
Return vs Industry: RDSM.Y underperformed the US Chemicals industry which returned -9.9% over the past year.
Return vs Market: RDSM.Y underperformed the US Market which returned -21.4% over the past year.
Price Volatility
| RDSM.Y volatility | |
|---|---|
| RDSM.Y Average Weekly Movement | 6.7% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RDSM.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: RDSM.Y's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 21,760 | Dimitri de Vreeze | www.dsm-firmenich.com |
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions.
DSM-Firmenich AG Fundamentals Summary
| RDSM.Y fundamental statistics | |
|---|---|
| Market cap | US$22.81b |
| Earnings (TTM) | US$1.12b |
| Revenue (TTM) | US$10.13b |
20.4x
P/E Ratio2.3x
P/S RatioIs RDSM.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RDSM.Y income statement (TTM) | |
|---|---|
| Revenue | €9.80b |
| Cost of Revenue | €6.48b |
| Gross Profit | €3.33b |
| Other Expenses | €2.24b |
| Earnings | €1.08b |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Feb 16, 2023
| Earnings per share (EPS) | 6.26 |
| Gross Margin | 33.92% |
| Net Profit Margin | 11.04% |
| Debt/Equity Ratio | 31.4% |
How did RDSM.Y perform over the long term?
See historical performance and comparison